Clever Leaves Holdings Inc. (NASDAQ:CLVR) has signed a one-year international sales agreement with German- Colombian operator FoliuMed Holdings and its German manufacturing partner, Fidelio Healthcare. With access to three of Clever Leaves’ pharmaceutical grade bulk cannabis extracts, Fidelio will be ramping up production using Clever Leaves’ full spectrum THC crude extract, standardized 20% CBD extract, and CBD isolate.
With high production standards recognized domestically and abroad, including both Good Manufacturing Practices certification from Colombia and European Union Good Manufacturing Practices certification from Europe, Clever Leaves’ Colombian pharmaceutical-grade cannabis will be utilized by Fidelio’s manufacturing and distribution teams to create affordable, orally administered gel capsules for consumption on a prescription basis by customers and patients in Australia, Europe and Latin America. Soft gel capsules are preferred by patients and doctors as they can be dosed more precisely than the market standard cannabis tinctures.
